We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-25.66%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$292M
AUM Growth
-$91.6M
Cap. Flow
+$21M
Cap. Flow %
7.18%
Top 10 Hldgs %
99.99%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VERO
Venus Concept
VERO
+$21M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$168M 57.29%
2,021,738
– –
GKOS icon
2
Glaukos
GKOS
$8.92B
$26.1M 8.93%
1,018,362
– –
EIGR
3
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$22.3M 7.63%
53,320
– –
MGNX icon
4
MacroGenics
MGNX
$254M
$20.4M 6.98%
1,074,316
– –
HIND
5
Vyome Holdings
HIND
$14M
– –
0
– –
VERO
6
DELISTED
Venus Concept
VERO
$15.4M 5.28%
+1,356
New +$21M
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$9.23M 3.15%
67,841
– –
IVTY
8
DELISTED
Invuity, Inc
IVTY
$6.7M 2.29%
1,080,272
– –
AGTC
9
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.24M 1.79%
1,455,904
– –
KALV
10
DELISTED
KalVista Pharmaceuticals
KALV
$3.22M 1.1%
329,942
– –
XENE icon
11
Xenon Pharmaceuticals
XENE
$6.36B
$23K 0.01%
8,293
– –

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q4 2017 Portfolio in Review

As of Q4 2017, InterWest Venture Management held 11 positions worth $292M, down 24% from $384M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management deployed $21M of net new capital in Q4 2017, opening 1 new position. Its largest new stake was Venus Concept: 1,356 shares worth $15.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • InterWest Venture Management's largest Q4 2017 buy was Venus Concept: 1,356 shares worth $15.4M.
  • InterWest Venture Management's ten largest holdings make up 100% of its $292M portfolio in Q4 2017.
  • InterWest Venture Management opened 1 new position and closed 0 in Q4 2017.
  • InterWest Venture Management's portfolio value fell 24% quarter-over-quarter to $292M.

Based on InterWest Venture Management's 13F filing for Q4 2017, filed 10 Jan 2018.